Palliative Care in Parkinson Disease—Is It Beneficial for All?-Reference-Cited by-同舟云学术

Palliative Care in Parkinson Disease—Is It Beneficial for All?

Published:2020-11-01 Issue:11 Volume:77 Page:1450
ISSN:2168-6149
Container-title:JAMA Neurology
language:en
Short-container-title:JAMA Neurol

Author:

Di Luca Daniel Garbin¹²,Singer Carlos¹,Margolesky Jason H.¹

Affiliation:

1. Department of Neurology, University of Miami Miller School of Medicine, Miami, Florida

2. Now with the Edmond J. Safra Program in Parkinson's Disease and the Morton & Gloria Shulman Movement Disorders Clinic, Division of Neurology, Department of Medicine, Toronto Western Hospital, University of Toronto, Toronto, Ontario, Canada

Publisher

American Medical Association (AMA)

Subject

Clinical Neurology

Link

https://jamanetwork.com/journals/jamaneurology/articlepdf/2769855/jamaneurology_di_luca_2020_le_200008_1604530395.93156.pdf

Reference5 articles.

1. Comparison of integrated outpatient palliative care with standard care in patients with Parkinson disease and related disorders: a randomized clinical trial.;Kluger;JAMA Neurol,2020

2. Bridging the gaps: more inclusive research needed to fully understand Parkinson’s disease.;Gilbert;Mov Disord,2020

3. Minority enrollment in Parkinson’s disease clinical trials.;Schneider;Parkinsonism Relat Disord,2009

4. Racial differences in palliative care use after stroke in majority-White, minority-serving, and racially integrated U.S. hospitals.;Faigle;Crit Care Med,2017

5. Racial and ethnic differences in end-of-life care in the United States: evidence from the Health and Retirement Study (HRS).;Orlovic;SSM Popul Health,2019

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ethnic background and distribution of clinical phenotypes in patients with probable progressive supranuclear palsy;Parkinsonism & Related Disorders;2024-06

2. Dopamine D1 Agonists: First Potential Treatment for Late-Stage Parkinson’s Disease;Biomolecules;2023-05-12

3. Dopamine D₁ agonist effects in late-stage Parkinson’s disease;2022-05-03